Activating KIR2DS5 receptor is a risk for thyroid cancer

Area of Science:

• Immunology
• Genetics
• Oncology

Background:

• Natural killer (NK) cells are crucial for innate immunity against tumors and infections.
• Killer cell immunoglobulin-like receptor (KIR) genes regulate NK cell function, with significant individual variability.
• Specific KIR genes have been linked to various diseases, prompting investigation into their role in cancer.

Purpose of the Study:

• To investigate the association between Killer cell immunoglobulin-like receptor (KIR) genes and the risk of developing thyroid cancer.
• To compare KIR gene profiles in thyroid cancer patients with healthy controls.

Main Methods:

• Utilized a gene-specific PCR typing system to analyze the presence and absence of 11 variable KIR genes in 85 thyroid cancer patients.
• Compared the KIR gene data from patients with previously published healthy control data.

Main Results:

• Thyroid cancer patients showed a trend towards increased activating KIR receptors compared to healthy controls.
• The activating KIR2DS5 gene was significantly more frequent in thyroid cancer patients.
• The Telomeric 4 (T4) gene cluster, including 3DS1-2DL5-2DS1 genes linked to KIR2DS5, was also more predominant in patients.

Conclusions:

• Specific activating KIR genes, such as KIR2DS5 and the T4 gene cluster, may be associated with an increased risk of thyroid cancer.
• These activating KIR genes might contribute to a pro-tumorigenic inflammatory microenvironment, potentially favoring tumor growth.
• Findings suggest a potential link between KIR gene polymorphisms and thyroid cancer susceptibility.